BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 16839274)

  • 1. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
    Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
    Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma.
    Höbel S; Appeldoorn CC; Gaillard PJ; Aigner A
    Pharmaceuticals (Basel); 2011 Dec; 4(12):1591-1606. PubMed ID: 27721338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression.
    Aigner A; Fischer D; Merdan T; Brus C; Kissel T; Czubayko F
    Gene Ther; 2002 Dec; 9(24):1700-7. PubMed ID: 12457284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.
    Zha L; He L; Xie W; Cheng J; Li T; Mohsen MO; Lei F; Storni F; Bachmann M; Chen H; Zhang Y
    PLoS One; 2017; 12(5):e0177964. PubMed ID: 28562667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long dsRNA-mediated RNA interference and immunostimulation: a targeted delivery approach using polyethyleneimine based nano-carriers.
    Sajeesh S; Lee TY; Hong SW; Dua P; Choe JY; Kang A; Yun WS; Song C; Park SH; Kim S; Li C; Lee DK
    Mol Pharm; 2014 Mar; 11(3):872-84. PubMed ID: 24521200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
    Grzelinski M; Bader N; Czubayko F; Aigner A
    Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
    Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A
    J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
    Höbel S; Aigner A
    Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
    Jin J; Bae KH; Yang H; Lee SJ; Kim H; Kim Y; Joo KM; Seo SW; Park TG; Nam DH
    Bioconjug Chem; 2011 Dec; 22(12):2568-72. PubMed ID: 22070554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo.
    Ewe A; Panchal O; Pinnapireddy SR; Bakowsky U; Przybylski S; Temme A; Aigner A
    Nanomedicine; 2017 Jan; 13(1):209-218. PubMed ID: 27553077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.
    Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M
    J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
    Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.